Effect of type-1 diabetes mellitus on the regulation of insulin and endothelin-1 receptors in rat hearts

Canadian Journal of Physiology and Pharmacology

Volumn 85, Issue 2, 2007, Pages 215-224

  Nuwayri Salti, Nuha ^a   Karam, Chehade N ^a   Al Jaroudi, Wael A ^a   Usta, Julnar A ^a   Maharsy, Wael M ^a   Bitar, Khalil M ^a   Bikhazi, Anwar B ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Cardiomyopathy; Endothelin 1 receptors; Insulin receptor; Insulin dependent diabetes mellitus; Receptor regulation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; INSULIN; INSULIN RECEPTOR; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FROZEN SECTION; HEART MUSCLE CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS, TYPE 1; ENDOTHELIN-1; FLUORESCENT ANTIBODY TECHNIQUE; LOSARTAN; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTOR, INSULIN;

EID: 34249791489     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y07-012     Document Type: Article

References (38)

1. Al Jaroudi, W.A., Nuwayri-Salti, N., Usta, J.A., Zwainy, D.S., Karam, C.N., Bitar, K.M., and Bikhazi, A.B. 2005. Effect of insulin and angiotensin II receptor subtype-1 antagonist on myocardial remodeling in rats with insulin-dependent-diabetes-mellitus. J. Hypertens. 23: 381-392. doi:10.1097/00004872-200502000-00021.
2. Chandramouli, V., and Carter, J.R., Jr. 1975. Cell membrane changes in chronically diabetic rats. Diabetes, 24: 257-262.
3. Chen, S., Evans, T., Mukherjee, K., Karmazyn, M., and Chakrabarti, S. 2000. Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors. J. Mol. Cell. Cardiol. 32: 1621-1629. doi:10.1006/jmcc. 2000.1197.
4. D'Uscio, L.V., Shaw, S., Barton, M., and Luscher, T.F. 1998. Losartan but not verapamil inhibits angiotensin H-induced tissue endothelin-1 increase. Role of blood pressure and endothelial function. Hypertension, 31: 1305-1310.
5. De Mello, W.C., and Danser, A.H. 2000. Angiotensin II and the heart: on the intracrine renin-angiotensin system. Hypertension, 35: 1183-1188.
6. Dhein, S., Hochreuther, S., Aus Dem Spring, C, Bollig, K., Hufnagel, C., and Raschack, M. 2000. Long-term effects of the endothelin (A) receptor antagonist LU135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type I diabetes mellitus rat model. J. Pharmacol. Exp. Ther. 293: 351-359.
7. Elbaz, N., Bedecs, K., Masson, M., Sutren, M., Strosberg, A.D., and Nahmias, C. 2000. Functional trans-activation of insulin receptor kinase by growth inhibitory angiotensin II AT2 receptor. Mol. Endocrinol. 14: 795-804. doi:10.1210/me.14.6.795.
8. Emori, T., Hirata, Y., and Marumo, F. 1990. Specific receptors for endothelin-3 in cultured bovine endothelial cells and its cellular mechanism of action. FEBS Lett. 263: 261-264. doi:10.1016/ 0014-5793(90)81388-5.
9. Filep, J.G., Foldes-Filep, E., Rousseau, A., Fournier, A., Sirois, P., and Yano, M. 1992. Endothelin-1 enhances vascular permeability in the rat heart through the ETA receptors. Eur. J. Pharmacol. 219: 343-344. doi:10.1016/0014-2999(92)90318-X.
10. Fiordaliso, F., Li, B., Latini, R., Sonnenblick, E.H., Anversa, P., Leri, A., and Kajstura, J. 2000. Myocyte death in streptozotocin-induced diabetes in rats is angiotensin II-dependent. Lab. Invest. 80: 513-527.
11. Folli, F., Kahn, C.R., Hansen, H., Bouchie, J., and Feener, E.P. 1997. Angiotensin II inhibits signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J. Clin. Invest. 100: 2158-2169.
12. Folli, F., Saad, M.J., Velloso, L., Hansen, H., Carandente, O., Feener, E.P., and Kahn, C.R. 1999. Crosstalk between insulin and angiotensin II signaling systems. Exp. Clin. Endocrinol. Diabetes, 107: 133-139.
13. Fukuda, G., Khan, Z.A., Barbin, Y.P., Farhangkhoee, H., Tilton, R.G., and Chakrabarti, S. 2005. Endothelin-mediated remodeling in aortas of diabetic rats. Diabetes Metab. Res. Rev. 21: 367-375. doi:10.1002/dmrr.527.
14. Furchgott, R.F., and Zawadzki, J.V. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (London), 288: 373-376. doi:10.1038/ 288373a0.
15. Heller, L.J., Opsahl, J.A., Wernsing, S.E., Saxena, R., and Katz, S.A. 1998. Myocardial and plasma renin-angiotensinogen dynamics during pressure-induced cardiac hypertrophy. Am. J. Physiol. 274: R849-R856.
16. Hirata, Y., Emori, T., Eguchi, S., Kanno, K., Imai, T., Ohta, K., and Marumo, F. 1993. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial Cells. J. Clin. Invest. 91: 1367-1373.
17. Honoré, J.-C., Proteau, C., and D'Orleans-Juste, P. 2002. Endothelin B receptors located on the endothelium provide cardiovascular protection in the hamster. Clin. Sci. 103: 280S-283S.
18. Hopfner, R.L., McNeill, J.R., and Gopalakrishnan, V. 1999. Plasma endothelin-1 levels and vascular responses at different temporal stages of streptozotocin diabetes. Eur. J. Pharmacol. 374: 221-227. doi:10.1016/S0014-2999(99)00316-7.
19. Ito, H., Hirata, Y., Adachi, S., Tanaka, M., Tsujino, M., Koike, A., et al. 1993. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J. Clin. Invest. 92: 398-403.
20. Jiang, Z.Y., Zhou, Q.L., Chatterjee, A., Feener, E.P., Myers, M.G., Jr., White, M.F., and King, G.L. 1999. Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes, 48: 1120-1130.
21. Kakoki, M., Hirata, Y., Hayakawa, H., Tojo, A., Nagata, D., Suzuki, E., et al. 1999. Effects of hypertension, diabetes mellitus, and hypercholesterolemia on endothelin type B receptor-mediated nitric oxide release from rat kidney. Circulation, 99: 1242-1248.
22. Karam, C.N., Nuwayri-Salti, N., Usta, J.A., Zwainy, D.S., Abrahamian, R.E., Al Jaroudi, W.A., et al. 2005. Effect of insulin and angiotensin II subtype-1 antagonist on endothelin receptor subtype(s) regulation and ninding in diabetic rat heart. Endothelium, 12: 225-231. doi:10.1080/ 10623320500476450.
23. Lin, Y.W., Duh, E., and Jiang, Z. 1996. Expression of preproendothelin-1 mRNA in streptozotocin-induced diabetic rats. Diabetes, 45 (Suppl. 2): 48A.
24. Masaki, T. 1998. The discovery of endothelins. Cardiovasc. Res. 39: 530-533. doi:10.1016/S0008-6363(98)00153-9.
25. Mitchell, D., Bihari, A., Sandig, M., and Tyml, K. 2002. Endothelin-A receptor in rat skeletal muscle microvasculature. Microvasc. Res. 64: 179-185. doi:10.1006/mvre.2002.2427.
26. Ono, K., Tsujimoto, G., Sakamoto, A., Eto, K., Masaki, T., Ozaki, Y., and Satake, M. 1994. Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature (London), 370: 301-304. doi:10.1038/370301a0.
27. Park, J.Y., Takahara, N., Gabriele, A., Chou, E., Naruse, K., Suzuma, K., et al. 2000. Induction of endothelin-1 expression by glucose. An effect of protein kinase C activation. Diabetes, 49: 1239-1248.
28. Passier, R.C., Smits, J.F., Verluyten, M.J., Studer, R., Drexler, H., and Daemen, M.J. 1995. Activation of angiotensin converting enzyme expression in infarct zone following myocardial infarction. Am. J. Physiol. 269: H1268-H1276.
29. Russell, F.D., and Molenaar, P. 2000. The human heart endothelin system: ET-1 synthesis, storage, release and effect. Trends Pharmacol. Sci. 21: 353-359. doi:10.1016/S0165-6147(00)01524-8.
30. Saito, M., Wada, Y., Ikeda, K., Wang, Z., Smith, S.D., Foster, H.E., et al. 2000. Gene expression, localization, and pharmacological characterization of endothelin receptors in diabetic rat bladder dome. Eur. J. Pharmacol. 387: 253-263. doi:10.1016/ S0014-2999(99)00753-0.
31. Sakurai, T., Morimoto, H., Kasuya, Y., Takuwa, Y., Nakauchi, H., Masaki, T., and Goto, K. 1992. Level of ETB receptor mRNA is down-regulated by endothelins through decreasing the intracellular stability of mRNA molecules. Biochem. Biophys. Res. Commun. 186: 342-347. doi:10.1016/S0006-291X(05) 80813-7.
32. Teerlink, J.R. 2002. Reversal of left ventricular remodeling: role of the endothelin pathway. J. Card. Fail. 8: S494-S499. doi:10. 1054/jcaf.2002.129288.
33. 2+ current in guinea-pig ventricular myocytes. J. Physiol. 503: 55-65. doi:10.1111/j.1469-7793.1997.055bi.x.
34. Velloso, L.A., Folli, F., Sun, X.J., White, M.F., Saad, M.J., and Kahn, C.R. 1996. Cross-talk between the insulin and angiotensin signaling systems. Proc. Natl. Acad. Sci. U.S.A. 93: 12490-12495. doi:10.1073/pnas.93.22. 12490.
35. Vesci, L., Mattera, G.G., Tobia, P., Corsico, N., and Calvani, M. 1995. Cardiac and renal endothelin-1 binding sites in streptozotocin-induced diabetic rats. Pharmacol. Res. 32: 363-367. doi:10.1016/S1043-6618(05)80041-6.
36. Wang, P.H., Almahfouz, A., Giorgino, F., McCowen, K.C., and Smith, R.J. 1999. In vivo insulin signaling in the myocardium of streptozotocin diabetic rats: opposite effects of diabetes on insulin stimulation of glycogen synthase and C-fos. Endocrinology, 140: 1141-1150. doi:10.1210/en.l40.3.1141.
37. Wendel-Wellner, M., Noll, T., Konig, P., Schmeck, J., Koch, T., and Kummer, W. 2002. Cellular localization of the endothelin receptor subtypes ETA and ETB in the rat heart and their differential expression in coronary arteries, veins, and capillaries. Histochem. Cell Biol. 118: 361-369. doi:10.1007/s00418-002-0457-4.
38. Zeng, G., and Quon, M.J. 1996. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J. Clin. Invest. 98: 894-898.